MARKETS
Company

Orchestra BioMed Announces Receipt Of $6.1M Milestone Payment From Haemonetics' Acquisition Of Vivasure Medica

Sep 15, 2026 · 08:31 AM ET· updated 1h ago

Share
Why It Matters

Orchestra BioMed got a $6.1 million payment from a deal. This shows the company is earning money from past business agreements.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.